Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Work In Process (2022 - 2026)

Neuroone Medical Technologies filings provide 5 years of Work In Process readings, the most recent being $292314.0 for Q1 2026.

  • On a quarterly basis, Work In Process fell 11.39% to $292314.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $292314.0, a 11.39% decrease, with the full-year FY2025 number at $130100.0, down 32.37% from a year prior.
  • Work In Process hit $292314.0 in Q1 2026 for Neuroone Medical Technologies, up from $135244.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $903554.0 in Q4 2022 to a low of $130100.0 in Q3 2025.
  • Median Work In Process over the past 5 years was $328368.0 (2025), compared with a mean of $330110.0.
  • Biggest five-year swings in Work In Process: crashed 64.84% in 2024 and later increased 28.95% in 2025.
  • Neuroone Medical Technologies' Work In Process stood at $903554.0 in 2022, then plummeted by 57.43% to $384659.0 in 2023, then crashed by 64.84% to $135254.0 in 2024, then fell by 0.01% to $135244.0 in 2025, then skyrocketed by 116.14% to $292314.0 in 2026.
  • The last three reported values for Work In Process were $292314.0 (Q1 2026), $135244.0 (Q4 2025), and $130100.0 (Q3 2025) per Business Quant data.